CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 15,000 shares (option exercise)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Acquisition or sale completed · Results of operations
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 4,573 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 4,469 shares (grant or award)
- 8-K Event Material agreement · Results of operations
Page 29 of 44 · 872 filings